Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy

Atherosclerotic cardiovascular diseases (ASCVD) are a very important cause of premature death. The most important risk factor for ASCVD is lipid disorders. The incidence of lipid disorders and ASCVD is constantly increasing, which means that new methods of prevention and treatment of these diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosnowska, Bożena, Surma, Stanisław, Banach, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781646/
https://www.ncbi.nlm.nih.gov/pubmed/36559024
http://dx.doi.org/10.3390/ph15121573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781646/
https://www.ncbi.nlm.nih.gov/pubmed/36559024
http://dx.doi.org/10.3390/ph15121573

Ejemplares similares